- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Forticell Bioscience Inc
+ Add to WatchlistFORBQ:US
0.0010 USD 0.00000.00%As of 20:10:00 ET on 04/18/2013.
Trading has been halted for FORBQ:US - Reason not available
Snapshot for Forticell Bioscience Inc (FORBQ)
| Open: | - | Day's Range: | - | Volume: | 1,000 |
|---|---|---|---|---|---|
| Previous Close: | 0.0010 | 52wk Range: | 0.0001 - 0.0895 | 1-Yr Rtn: | - |
Key Statistics for FORBQ
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.3100 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.01 |
| Shares Outstanding (M) | 13.36 |
| 30 Day Average Volume | 516 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for FORBQ
No data available
Company Profile & Key Executives for FORBQ
Forticell Bioscience, Inc. produces Composite Cultured Skin, a biologically active dressing that stimulates the repair, replacement, and regeneration of human skin. The Company's product is used in the treatment of various skin wounds, including partial thickness burns, venous statis ulcers and diabetic ulcers, and damage from Epidermolysis Bullosa disease.
| Shepard M GoldbergChairman | Alan W SchoenbartCEO/CFO |
| Melvin SilberklangVP/Chief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
FORBQ News
-
Industry News
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page